XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue (Tables)
9 Months Ended
Sep. 30, 2022
Revenue.  
Summary of revenue disaggregated by product

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2022

2021

2022

2021

Revenue

Lymphedema products

$

54,214

$

51,636

$

146,502

$

145,468

Airway clearance products

11,048

861

26,383

861

Total

$

65,262

$

52,497

$

172,885

$

146,329

Percentage of total revenue

Lymphedema products

 

83%

 

98%

 

85%

 

99%

Airway clearance products

17%

2%

15%

1%

Total

 

100%

 

100%

 

100%

 

100%

Summary of revenue by channel

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2022

2021

2022

2021

Private insurers and other payers

$

36,188

$

36,034

$

97,726

$

99,665

Veterans Administration

6,755

6,737

19,118

19,905

Medicare

11,271

8,865

29,658

25,898

Durable medical equipment distributors

11,048

861

26,383

861

Total

$

65,262

$

52,497

$

172,885

$

146,329

Sales-type lease revenue and the associated cost of goods sold

Three Months Ended September 30,

Nine Months Ended September 30,

(In thousands)

2022

2021

2022

2021

Sales-type lease revenue

$

9,717

$

8,037

$

24,905

$

22,114

Cost of sales-type lease revenue

 

2,992

 

2,433

 

7,640

 

6,501

Gross profit

$

6,725

$

5,604

$

17,265

$

15,613